PBC-specific antinuclear antibody ANA expression identified by immunofluorescence, specific anti-sp100/anti-gp210 expression identified Western blotting, or enzyme-linked immunosorbent assay (ELISA) results inform the diagnosis of PBC [7, 8]. This evidence concerns the gene NUP210 and primary biliary cholangitis.